TABAKPROTEASEGENE

European patent · EP3169149 · In force

Register entry

Publication number
EP3169149
Application number
EP15738907
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 16, 2015
Published
May 24, 2017
Granted
Jan 17, 2024
Protection ends at the latest
Jul 15, 2035
Next annual fee due
Jul 31, 2026
IPC classes
C12N 9/10 (2006.01)
C12N 9/48 (2006.01)
C12N 9/50 (2006.01)
C12N 15/82 (2006.01)
A24B 3/12 (2006.01)
Priority
EP 14177715 18.07.2014
PCT application
PCT/EP2015/066341 16.07.2015
PCT publication
WO2016/009006 21.01.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2025

    Change

    Published in Swissreg on 01.08.2025

  2. Nov 27, 2024

    Change

    Published in Swissreg on 27.11.2024

  3. Aug 1, 2024

    Change

    Published in Swissreg on 01.08.2024

  4. Jan 18, 2024

    Agent entered

    Representative
    Murgitroyd & Company, Geneva Rhone 8 Sàrl, Rue du Commerce 4, 1204 Genève

    Published in Swissreg on 18.01.2024

  5. Jan 17, 2024

    Granted

    Published in Swissreg on 17.01.2024

Parties

Holder

Philip Morris Products S.A.

Quai Jeanrenaud 3, 2000 Neuchâtel

Agent

Murgitroyd & Company

Geneva Rhone 8 Sàrl Rue du Commerce 4, 1204 Genève

Inventor

FLORACK, Dion

2525 Le Landeron

BATTEY, James

2000 Neuchatel

BOVET, Lucien

2300 La-chaux-de-Fon

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.